Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Medical College of Wisconsin
Medical College of Wisconsin
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Roswell Park Cancer Institute
New Approaches to Neuroblastoma Therapy Consortium
University of Washington
University of Washington
Ludwig Institute for Cancer Research
Mayo Clinic
Ludwig Institute for Cancer Research
Roswell Park Cancer Institute
University of Colorado, Denver
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
National Cancer Institute (NCI)
University of Virginia
Roswell Park Cancer Institute
San Antonio Military Medical Center
Abramson Cancer Center at Penn Medicine
Regeneron Pharmaceuticals
National Institutes of Health Clinical Center (CC)
Technical University of Munich
University of Wisconsin, Madison
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University of Washington
St. Jude Children's Research Hospital
Mayo Clinic
Immatics Biotechnologies GmbH
Mayo Clinic
Dartmouth-Hitchcock Medical Center
Providence Health & Services
Dartmouth-Hitchcock Medical Center
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
University of Washington
University of California, San Francisco
University of Pittsburgh
Roswell Park Cancer Institute
Alliance for Clinical Trials in Oncology
Benovus Bio, Inc.
Memorial Sloan Kettering Cancer Center
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
Cancer Research UK
National Cancer Institute (NCI)
Roger Williams Medical Center